Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node.
We treated 6 patients with recurrent oral cancer and metastasis to the cervical lymph nodes after conventional treatments in 5 and non-conventional in 1 using BNCT, and herein report our results. The clinical response in our patients ranged from CR to PD. In 5 cases, spontaneous pain decreased immediately after BNCT. Three of the 6 are alive at the time of writing and we found that BNCT contributed to QOL improvement in all.
Kimura
Y
Y
Department of Dentistry and Oral Surgery, Division of Medicine for Function and Morphology of Sensory Organs, Osaka Medical College, 2-7 Daigaku-machi Takatsuki City, Osaka, Japan. ora018@poh.osaka-med.ac.jp
Ariyoshi
Y
Y
Shimahara
M
M
Miyatake
S
S
Kawabata
S
S
Ono
K
K
Suzuki
M
M
Maruhashi
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001896:Boron Compounds / Q000627:therapeutic use; D016754:Boron Neutron Capture Therapy; D005260:Female; D005462:Fluorine Radioisotopes; D006801:Humans; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000532:radiotherapy*; D009333:Neck; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000532:radiotherapy*; D010146:Pain / Q000503:physiopathology; D010649:Phenylalanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D049268:Positron-Emission Tomography; D011788:Quality of Life; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed
D001896:Boron Compounds; D005462:Fluorine Radioisotopes; D011838:Radiation-Sensitizing Agents; D019275:Radiopharmaceuticals; C072915:4-borono-2-fluorophenylalanine; D010649:Phenylalanine; C033685:4-boronophenylalanine